Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.
Colorectal liver metastases (CRLM)
Efficacy
Irreversible electroporation (IRE)
Recurrence
Safety
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
09
03
2021
accepted:
18
09
2021
pubmed:
11
11
2021
medline:
4
2
2022
entrez:
10
11
2021
Statut:
ppublish
Résumé
To examine the safety and short-term oncologic outcomes of computer-tomography-guided (CT-guided) irreversible electroporation (IRE) of recurrent, irresectable colorectal liver metastases (CRLM) after major hepatectomy deemed unsuitable for thermal ablation. Twenty-three patients undergoing CT-guided IRE of recurrent CRLM after major hepatectomy were included in this study. All tumors were located adjacent to sole remaining intrahepatic blood vessels and bile ducts, precluding thermal ablation. Patients underwent systematic clinical and imaging follow-up, including magnetic resonance imaging of the liver at 1-month and 3-month intervals thereafter. Time to local and intrahepatic tumor progression within 12 and 36 months and associated risk factors were assessed using Kaplan Meier and Cox regression analysis, respectively. Complete ablation with a safety margin of at least 0.5 cm was achieved in 22/23 (95.6%) patients. No vessel injury or thrombosis occurred. Five patients developed moderate biliary stenosis after a median of 4 weeks, without requiring treatment. Local tumor-progression-free rates within 12/36 months were 64%/57.4%, respectively. Intrahepatic-progression-free rate within 12/36 months was 36.4%/19.5%, respectively. Five (23%) patients were tumor-free at the end of follow-up. Multivariate Cox regression analysis did not show any association between local tumor-progression-free rates and patient age, target tumor size, primary tumor side or synchronicity of liver metastases. In this highly selected patient population with local recurrences of CRLM after major surgery, IRE was shown to be a safe salvage treatment option when thermal ablation is unsuitable.
Identifiants
pubmed: 34757483
doi: 10.1007/s00270-021-02981-4
pii: 10.1007/s00270-021-02981-4
pmc: PMC8807435
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
182-189Informations de copyright
© 2021. The Author(s).
Références
J Vasc Interv Radiol. 2011 Jun;22(6):755-61
pubmed: 21514841
Cardiovasc Intervent Radiol. 2015 Apr;38(2):401-8
pubmed: 25609208
Clin Colorectal Cancer. 2021 Jun;20(2):e82-e95
pubmed: 33246789
Trials. 2018 Feb 13;19(1):105
pubmed: 29439711
BMC Cancer. 2015 Oct 24;15:772
pubmed: 26497813
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
BMC Cancer. 2018 Aug 15;18(1):821
pubmed: 30111304
Eur J Cancer. 2014 Mar;50(5):912-9
pubmed: 24411080
J Vasc Interv Radiol. 2020 Nov;31(11):1765-1771.e15
pubmed: 32978054
Radiology. 2017 Dec;285(3):1023-1031
pubmed: 28799842
Radiology. 2014 Oct;273(1):241-60
pubmed: 24927329
Radiology. 2005 Jul;236(1):132-9
pubmed: 15987969
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635230
Am J Transplant. 2007 Jul;7(7):1788-96
pubmed: 17524079
J Vasc Interv Radiol. 2014 Aug;25(8):1233-1239.e2
pubmed: 24861662
J Clin Transl Res. 2020 Mar 12;5(3):109-132
pubmed: 32617426
Can Assoc Radiol J. 2018 Feb;69(1):38-50
pubmed: 29458954
Eur Radiol. 2020 Feb;30(2):1221-1227
pubmed: 31493210
Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75
pubmed: 22535243
N Engl J Med. 2007 Apr 12;356(15):1545-59
pubmed: 17429086
Cardiovasc Intervent Radiol. 2019 Apr;42(4):577-583
pubmed: 30465255
Am J Transplant. 2005 Nov;5(11):2605-10
pubmed: 16212618
Radiology. 2012 Dec;265(3):958-68
pubmed: 23091175
J Vasc Interv Radiol. 2014 Jan;25(1):112-8
pubmed: 24262034
J Am Coll Surg. 2012 Sep;215(3):379-87
pubmed: 22704820
Radiology. 2016 Feb;278(2):601-11
pubmed: 26267832
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
HPB (Oxford). 2020 Apr;22(4):487-496
pubmed: 31786053
J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1
pubmed: 29203394
Cardiovasc Intervent Radiol. 2015 Oct;38(5):1349-51
pubmed: 25986464
J Vasc Interv Radiol. 2016 Jan;27(1):96-103
pubmed: 26777402
Cardiovasc Intervent Radiol. 2020 Jul;43(7):951-962
pubmed: 32382856
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809994
pubmed: 30411673
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Ann Surg. 2005 Aug;242(2):158-71
pubmed: 16041205
Cardiovasc Intervent Radiol. 2015 Feb;38(1):152-9
pubmed: 24798135
Radiology. 2021 May;299(2):470-480
pubmed: 33724066